Lidocaine is chemically known as acetamide, 2- (diethylamino) -n - (2, 6-dimethyl phenyl), octanol at pH 7.4;Moisture ratio for 43, lidocaine transdermal patch is suitable for adults and adolescents 12 years of age or temporary pain relief including 5% lidocaine transdermal patches, 1.8% lidocaine transdermal patches, 4% lidocaine transdermal patches containing 5%, 1.8% and 4% respectively of lidocaine adhesive materials, the material paste on nonwoven polyester felt backing, and covered with polyethylene terephthalate (PET) film stripping gasket, before the break on the skin, to remove off lining.
The global Lidocaine Transdermal Patch market is projected to grow from US$ 209.3 million in 2024 to US$ 249.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.0% during the forecast period.
The US & Canada market for Lidocaine Transdermal Patch is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Lidocaine Transdermal Patch is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Lidocaine Transdermal Patch is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Lidocaine Transdermal Patch include Teikoku, Teva Pharmaceutical, Sorrento Therapeutics, Hisamitsu, Endo International, Par Pharmaceutical, Mylan and Tide Pharmaceutical (SINO BIOPHARM), etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Lidocaine Transdermal Patch, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Lidocaine Transdermal Patch, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Lidocaine Transdermal Patch, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lidocaine Transdermal Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Lidocaine Transdermal Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Lidocaine Transdermal Patch sales, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Sorrento Therapeutics
Hisamitsu
Endo International
Par Pharmaceutical
Mylan
Tide Pharmaceutical (SINO BIOPHARM)
Segment by Type
Lidocare 5% Transdermal Patch
Lidocare 1.80% Transdermal Patch
Lidocare 4% Transdermal Patch
Segment by Application
Online Pharmacies
Hospital Pharmacies
Clinic
Monomer Pharmacies
Chain Pharmacies
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Lidocaine Transdermal Patch in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Lidocaine Transdermal Patch manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lidocaine Transdermal Patch sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Lidocaine Transdermal Patch Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Lidocaine Transdermal Patch 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Lidocare 5% Transdermal Patch
1.2.3 Lidocare 1.80% Transdermal Patch
1.2.4 Lidocare 4% Transdermal Patch
1.3 麻豆原创 by Application
1.3.1 Global Lidocaine Transdermal Patch 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Online Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Clinic
1.3.5 Monomer Pharmacies
1.3.6 Chain Pharmacies
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Lidocaine Transdermal Patch Sales Estimates and Forecasts 2019-2030
2.2 Global Lidocaine Transdermal Patch Revenue by Region
2.2.1 Global Lidocaine Transdermal Patch Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Lidocaine Transdermal Patch Revenue by Region (2019-2024)
2.2.3 Global Lidocaine Transdermal Patch Revenue by Region (2025-2030)
2.2.4 Global Lidocaine Transdermal Patch Revenue 麻豆原创 Share by Region (2019-2030)
2.3 Global Lidocaine Transdermal Patch Sales Estimates and Forecasts 2019-2030
2.4 Global Lidocaine Transdermal Patch Sales by Region
2.4.1 Global Lidocaine Transdermal Patch Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Lidocaine Transdermal Patch Sales by Region (2019-2024)
2.4.3 Global Lidocaine Transdermal Patch Sales by Region (2025-2030)
2.4.4 Global Lidocaine Transdermal Patch Sales 麻豆原创 Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Lidocaine Transdermal Patch Sales by Manufacturers
3.1.1 Global Lidocaine Transdermal Patch Sales by Manufacturers (2019-2024)
3.1.2 Global Lidocaine Transdermal Patch Sales 麻豆原创 Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lidocaine Transdermal Patch in 2023
3.2 Global Lidocaine Transdermal Patch Revenue by Manufacturers
3.2.1 Global Lidocaine Transdermal Patch Revenue by Manufacturers (2019-2024)
3.2.2 Global Lidocaine Transdermal Patch Revenue 麻豆原创 Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Lidocaine Transdermal Patch Revenue in 2023
3.3 Global Key Players of Lidocaine Transdermal Patch, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Lidocaine Transdermal Patch Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
3.5.2 Global Lidocaine Transdermal Patch 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Lidocaine Transdermal Patch, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Lidocaine Transdermal Patch, Product Offered and Application
3.8 Global Key Manufacturers of Lidocaine Transdermal Patch, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 麻豆原创 Size by Type
4.1 Global Lidocaine Transdermal Patch Sales by Type
4.1.1 Global Lidocaine Transdermal Patch Historical Sales by Type (2019-2024)
4.1.2 Global Lidocaine Transdermal Patch Forecasted Sales by Type (2025-2030)
4.1.3 Global Lidocaine Transdermal Patch Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Lidocaine Transdermal Patch Revenue by Type
4.2.1 Global Lidocaine Transdermal Patch Historical Revenue by Type (2019-2024)
4.2.2 Global Lidocaine Transdermal Patch Forecasted Revenue by Type (2025-2030)
4.2.3 Global Lidocaine Transdermal Patch Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Lidocaine Transdermal Patch Price by Type
4.3.1 Global Lidocaine Transdermal Patch Price by Type (2019-2024)
4.3.2 Global Lidocaine Transdermal Patch Price Forecast by Type (2025-2030)
5 麻豆原创 Size by Application
5.1 Global Lidocaine Transdermal Patch Sales by Application
5.1.1 Global Lidocaine Transdermal Patch Historical Sales by Application (2019-2024)
5.1.2 Global Lidocaine Transdermal Patch Forecasted Sales by Application (2025-2030)
5.1.3 Global Lidocaine Transdermal Patch Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Lidocaine Transdermal Patch Revenue by Application
5.2.1 Global Lidocaine Transdermal Patch Historical Revenue by Application (2019-2024)
5.2.2 Global Lidocaine Transdermal Patch Forecasted Revenue by Application (2025-2030)
5.2.3 Global Lidocaine Transdermal Patch Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Lidocaine Transdermal Patch Price by Application
5.3.1 Global Lidocaine Transdermal Patch Price by Application (2019-2024)
5.3.2 Global Lidocaine Transdermal Patch Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Lidocaine Transdermal Patch 麻豆原创 Size by Type
6.1.1 US & Canada Lidocaine Transdermal Patch Sales by Type (2019-2030)
6.1.2 US & Canada Lidocaine Transdermal Patch Revenue by Type (2019-2030)
6.2 US & Canada Lidocaine Transdermal Patch 麻豆原创 Size by Application
6.2.1 US & Canada Lidocaine Transdermal Patch Sales by Application (2019-2030)
6.2.2 US & Canada Lidocaine Transdermal Patch Revenue by Application (2019-2030)
6.3 US & Canada Lidocaine Transdermal Patch 麻豆原创 Size by Country
6.3.1 US & Canada Lidocaine Transdermal Patch Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Lidocaine Transdermal Patch Sales by Country (2019-2030)
6.3.3 US & Canada Lidocaine Transdermal Patch Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Lidocaine Transdermal Patch 麻豆原创 Size by Type
7.1.1 Europe Lidocaine Transdermal Patch Sales by Type (2019-2030)
7.1.2 Europe Lidocaine Transdermal Patch Revenue by Type (2019-2030)
7.2 Europe Lidocaine Transdermal Patch 麻豆原创 Size by Application
7.2.1 Europe Lidocaine Transdermal Patch Sales by Application (2019-2030)
7.2.2 Europe Lidocaine Transdermal Patch Revenue by Application (2019-2030)
7.3 Europe Lidocaine Transdermal Patch 麻豆原创 Size by Country
7.3.1 Europe Lidocaine Transdermal Patch Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Lidocaine Transdermal Patch Sales by Country (2019-2030)
7.3.3 Europe Lidocaine Transdermal Patch Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Lidocaine Transdermal Patch 麻豆原创 Size
8.1.1 China Lidocaine Transdermal Patch Sales (2019-2030)
8.1.2 China Lidocaine Transdermal Patch Revenue (2019-2030)
8.2 China Lidocaine Transdermal Patch 麻豆原创 Size by Application
8.2.1 China Lidocaine Transdermal Patch Sales by Application (2019-2030)
8.2.2 China Lidocaine Transdermal Patch Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Lidocaine Transdermal Patch 麻豆原创 Size by Type
9.1.1 Asia Lidocaine Transdermal Patch Sales by Type (2019-2030)
9.1.2 Asia Lidocaine Transdermal Patch Revenue by Type (2019-2030)
9.2 Asia Lidocaine Transdermal Patch 麻豆原创 Size by Application
9.2.1 Asia Lidocaine Transdermal Patch Sales by Application (2019-2030)
9.2.2 Asia Lidocaine Transdermal Patch Revenue by Application (2019-2030)
9.3 Asia Lidocaine Transdermal Patch Sales by Region
9.3.1 Asia Lidocaine Transdermal Patch Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Lidocaine Transdermal Patch Revenue by Region (2019-2030)
9.3.3 Asia Lidocaine Transdermal Patch Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Lidocaine Transdermal Patch 麻豆原创 Size by Type
10.1.1 Middle East, Africa and Latin America Lidocaine Transdermal Patch Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Lidocaine Transdermal Patch Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Lidocaine Transdermal Patch 麻豆原创 Size by Application
10.2.1 Middle East, Africa and Latin America Lidocaine Transdermal Patch Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Lidocaine Transdermal Patch Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Lidocaine Transdermal Patch Sales by Country
10.3.1 Middle East, Africa and Latin America Lidocaine Transdermal Patch Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Lidocaine Transdermal Patch Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Lidocaine Transdermal Patch Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Teikoku
11.1.1 Teikoku Company Information
11.1.2 Teikoku Overview
11.1.3 Teikoku Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Teikoku Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teikoku Recent Developments
11.2 Teva Pharmaceutical
11.2.1 Teva Pharmaceutical Company Information
11.2.2 Teva Pharmaceutical Overview
11.2.3 Teva Pharmaceutical Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Teva Pharmaceutical Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Pharmaceutical Recent Developments
11.3 Sorrento Therapeutics
11.3.1 Sorrento Therapeutics Company Information
11.3.2 Sorrento Therapeutics Overview
11.3.3 Sorrento Therapeutics Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Sorrento Therapeutics Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sorrento Therapeutics Recent Developments
11.4 Hisamitsu
11.4.1 Hisamitsu Company Information
11.4.2 Hisamitsu Overview
11.4.3 Hisamitsu Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Hisamitsu Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hisamitsu Recent Developments
11.5 Endo International
11.5.1 Endo International Company Information
11.5.2 Endo International Overview
11.5.3 Endo International Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Endo International Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Endo International Recent Developments
11.6 Par Pharmaceutical
11.6.1 Par Pharmaceutical Company Information
11.6.2 Par Pharmaceutical Overview
11.6.3 Par Pharmaceutical Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Par Pharmaceutical Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Par Pharmaceutical Recent Developments
11.7 Mylan
11.7.1 Mylan Company Information
11.7.2 Mylan Overview
11.7.3 Mylan Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Mylan Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mylan Recent Developments
11.8 Tide Pharmaceutical (SINO BIOPHARM)
11.8.1 Tide Pharmaceutical (SINO BIOPHARM) Company Information
11.8.2 Tide Pharmaceutical (SINO BIOPHARM) Overview
11.8.3 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Tide Pharmaceutical (SINO BIOPHARM) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lidocaine Transdermal Patch Industry Chain Analysis
12.2 Lidocaine Transdermal Patch Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lidocaine Transdermal Patch Production Mode & Process
12.4 Lidocaine Transdermal Patch Sales and 麻豆原创ing
12.4.1 Lidocaine Transdermal Patch Sales Channels
12.4.2 Lidocaine Transdermal Patch Distributors
12.5 Lidocaine Transdermal Patch Customers
13 麻豆原创 Dynamics
13.1 Lidocaine Transdermal Patch Industry Trends
13.2 Lidocaine Transdermal Patch 麻豆原创 Drivers
13.3 Lidocaine Transdermal Patch 麻豆原创 Challenges
13.4 Lidocaine Transdermal Patch 麻豆原创 Restraints
14 Key Findings in The Global Lidocaine Transdermal Patch Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Teikoku
Teva Pharmaceutical
Sorrento Therapeutics
Hisamitsu
Endo International
Par Pharmaceutical
Mylan
Tide Pharmaceutical (SINO BIOPHARM)
听
听
*If Applicable.